Ines Florath1, Katja Butterbach2, Jonathan Heiss2, Melanie Bewerunge-Hudler3, Yan Zhang2, Ben Schöttker2, Hermann Brenner2,4,5. 1. Division of Clinical Epidemiology and Aging Research (C070), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 581, 69120, Heidelberg, Germany. i.florath@gmx.de. 2. Division of Clinical Epidemiology and Aging Research (C070), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 581, 69120, Heidelberg, Germany. 3. Core Facility Genomics & Proteomics, German Cancer Research Center (DKFZ), Heidelberg, Germany. 4. Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany. 5. German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
Abstract
AIMS/HYPOTHESIS: Development of type 2 diabetes depends on environmental and genetic factors. We investigated the epigenome-wide association of prevalent diabetes with DNA methylation (DNAm) in peripheral blood. METHODS: DNAm was measured in whole blood with the Illumina Infinium HumanMethylation450 BeadChip in two subsamples of participants from the ESTHER cohort study. Cohort 1 included 988 participants, who were consecutively recruited between July and October 2000 and cohort 2 included 527 randomly selected participants. The association of DNAm with prevalent type 2 diabetes at recruitment was estimated using median regression analysis adjusting for sex, age, BMI, smoking behaviour, cell composition and batch at 361,922 CpG sites. RESULTS: Type 2 diabetes was prevalent in 16% of the participants, and diabetes was poorly controlled in 45% of the diabetic patients. In cohort 1 (discovery) DNAm at 39 CpGs was significantly associated with prevalent diabetes after correction for multiple testing. In cohort 2 (replication) at one of these CpGs, DNAm was still significantly associated. Decreasing methylation levels at cg19693031 with increasing fasting glucose and HbA1c concentrations were observed using restricted cubic spline analysis. In diabetic patients with poorly controlled diabetes, the decrease in estimated DNAm levels was approximately 5% in comparison with participants free of diagnosed diabetes. CONCLUSIONS/ INTERPRETATION: Cg19693031, which is located within the 3'-untranslated region of TXNIP, might play a role in the pathophysiology of type 2 diabetes. This result appears biologically plausible given that thioredoxin-interacting protein is overexpressed in diabetic animals and humans and 3'-untranslated regions are known to play a regulatory role in gene expression.
AIMS/HYPOTHESIS: Development of type 2 diabetes depends on environmental and genetic factors. We investigated the epigenome-wide association of prevalent diabetes with DNA methylation (DNAm) in peripheral blood. METHODS: DNAm was measured in whole blood with the Illumina Infinium HumanMethylation450 BeadChip in two subsamples of participants from the ESTHER cohort study. Cohort 1 included 988 participants, who were consecutively recruited between July and October 2000 and cohort 2 included 527 randomly selected participants. The association of DNAm with prevalent type 2 diabetes at recruitment was estimated using median regression analysis adjusting for sex, age, BMI, smoking behaviour, cell composition and batch at 361,922 CpG sites. RESULTS:Type 2 diabetes was prevalent in 16% of the participants, and diabetes was poorly controlled in 45% of the diabeticpatients. In cohort 1 (discovery) DNAm at 39 CpGs was significantly associated with prevalent diabetes after correction for multiple testing. In cohort 2 (replication) at one of these CpGs, DNAm was still significantly associated. Decreasing methylation levels at cg19693031 with increasing fasting glucose and HbA1c concentrations were observed using restricted cubic spline analysis. In diabeticpatients with poorly controlled diabetes, the decrease in estimated DNAm levels was approximately 5% in comparison with participants free of diagnosed diabetes. CONCLUSIONS/ INTERPRETATION:Cg19693031, which is located within the 3'-untranslated region of TXNIP, might play a role in the pathophysiology of type 2 diabetes. This result appears biologically plausible given that thioredoxin-interacting protein is overexpressed in diabetic animals and humans and 3'-untranslated regions are known to play a regulatory role in gene expression.
Entities:
Keywords:
450k array; DNA methylation; Epigenome-wide; Illumina Infinium HumanMethylation450 BeadChip; Peripheral blood; Type 2 diabetes
Authors: Michael C Wu; Bonnie R Joubert; Pei-fen Kuan; Siri E Håberg; Wenche Nystad; Shyamal D Peddada; Stephanie J London Journal: Epigenetics Date: 2013-11-15 Impact factor: 4.528
Authors: Natalie S Shenker; Silvia Polidoro; Karin van Veldhoven; Carlotta Sacerdote; Fulvio Ricceri; Mark A Birrell; Maria G Belvisi; Robert Brown; Paolo Vineis; James M Flanagan Journal: Hum Mol Genet Date: 2012-11-21 Impact factor: 6.150
Authors: Jordana T Bell; Pei-Chien Tsai; Tsun-Po Yang; Ruth Pidsley; James Nisbet; Daniel Glass; Massimo Mangino; Guangju Zhai; Feng Zhang; Ana Valdes; So-Youn Shin; Emma L Dempster; Robin M Murray; Elin Grundberg; Asa K Hedman; Alexandra Nica; Kerrin S Small; Emmanouil T Dermitzakis; Mark I McCarthy; Jonathan Mill; Tim D Spector; Panos Deloukas Journal: PLoS Genet Date: 2012-04-19 Impact factor: 5.917
Authors: Bertha Hidalgo; M Ryan Irvin; Jin Sha; Degui Zhi; Stella Aslibekyan; Devin Absher; Hemant K Tiwari; Edmond K Kabagambe; Jose M Ordovas; Donna K Arnett Journal: Diabetes Date: 2013-10-29 Impact factor: 9.461
Authors: Zhuo Chen; Feng Miao; Andrew D Paterson; John M Lachin; Lingxiao Zhang; Dustin E Schones; Xiwei Wu; Jinhui Wang; Joshua D Tompkins; Saul Genuth; Barbara H Braffett; Arthur D Riggs; Rama Natarajan Journal: Proc Natl Acad Sci U S A Date: 2016-05-09 Impact factor: 11.205
Authors: S Sayols-Baixeras; I Subirana; C Lluis-Ganella; F Civeira; J Roquer; A N Do; D Absher; A Cenarro; D Muñoz; C Soriano-Tárraga; J Jiménez-Conde; J M Ordovas; M Senti; S Aslibekyan; J Marrugat; D K Arnett; R Elosua Journal: Hum Mol Genet Date: 2016-10-15 Impact factor: 6.150
Authors: Karlijn A C Meeks; Peter Henneman; Andrea Venema; Juliet Addo; Silver Bahendeka; Tom Burr; Ina Danquah; Cecilia Galbete; Marcel M A M Mannens; Frank P Mockenhaupt; Ellis Owusu-Dabo; Charles N Rotimi; Matthias B Schulze; Liam Smeeth; Joachim Spranger; Mohammad H Zafarmand; Adebowale Adeyemo; Charles Agyemang Journal: Int J Epidemiol Date: 2019-02-01 Impact factor: 7.196
Authors: Robert Philibert; Jeffrey D Long; James A Mills; S R H Beach; Frederick X Gibbons; Meg Gerrard; Ron Simons; Paulo B Pinho; Douglas Ingle; Kelsey Dawes; Timur Dogan; Meeshanthini Dogan Journal: Epigenetics Date: 2020-11-02 Impact factor: 4.528